We are live on ! Find out more
GP

GLG Partners Portfolio holdings

AUM $2.14B
1-Year Est. Return 21.14%
This Fund
S&P 500
This Quarter Est. Return
+5.42%
1 Year Est. Return
+21.14%
3 Year Est. Return
+49.84%
5 Year Est. Return
10 Year Est. Return
AUM
$2.14B
AUM Growth
+$251M
Cap. Flow
-$130M
Cap. Flow %
-6.09%
Top 10 Hldgs %
20.07%
Holding
564
New
243
Increased
78
Reduced
76
Closed
91

Sector Composition

Rank Sector Weight
1 Miscellaneous 27.22%
2 Consumer Discretionary 13.47%
3 Technology 9.7%
4 Financials 9.51%
5 Industrials 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DDC
501
DELISTED
Dominion Diamond Corporation
DDC
-769,898
Closed -$10.9M
FDC
502
DELISTED
First Data Corporation
FDC
-24,751
Closed -$447K

Similar funds

GLG Partners's Q4 2017 Portfolio in Review

As of Q4 2017, GLG Partners held 564 positions worth $2.14B, up 13% from $1.89B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

GLG Partners withdrew a net $130M in Q4 2017, closing 91 positions and reducing 76 holdings. Its most notable exit was Sciclone Pharmaceuticals Inc, an estimated $29M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 36% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, GLG Partners opened a new position in Advanced Accelerator Applications S.A. worth $49.2M.

  • GLG Partners's largest Q4 2017 buy was Advanced Accelerator Applications S.A.: 603,055 shares worth $49.2M.
  • GLG Partners added most to NXP Semiconductors in Q4 2017, an estimated $35M increase.
  • GLG Partners's biggest Q4 2017 reduction was Criteo S.A., cutting an estimated $22.5M.
  • GLG Partners fully exited Sciclone Pharmaceuticals Inc in Q4 2017, selling an estimated $29M.
  • GLG Partners's ten largest holdings make up 20% of its $2.14B portfolio in Q4 2017.
  • GLG Partners opened 243 new positions and closed 91 in Q4 2017.
  • GLG Partners's portfolio value rose 13% quarter-over-quarter to $2.14B.

Based on GLG Partners's 13F filing for Q4 2017, filed 14 Feb 2018.